P. Blandina et al., INHIBITION OF CORTICAL ACETYLCHOLINE-RELEASE AND COGNITIVE PERFORMANCE BY HISTAMINE H-3 RECEPTOR ACTIVATION IN RATS, British Journal of Pharmacology, 119(8), 1996, pp. 1656-1664
1 The effects of histamine and agents acting at histamine receptors on
spontaneous and 100 mM K+-evoked release of acetylcholine, measured b
y microdialysis from the cortex of freely moving rats, and on cognitiv
e tests are described. 2 Local administration of histamine (0.1-100 mu
M) failed to affect spontaneous but inhibited 100 mM K+-stimulated re
lease of acetylcholine up to about 50%. The H-3 receptor agonists (R)-
alpha-methylhistamine (RAMH) (0.1-10 mu M), imetit (0.01-10 mu M) and
immepip (0.01-10 mu M) mimicked the effect of histamine. 3 Neither 2-t
hiazolylethylamine (TEA), an agonist showing some selectivity for H-1
receptors, nor the H-2 receptor agonist, dimaprit, modified 100 mM K+-
evoked release of acetylcholine. 4 The inhibitory effect of 100 mu M h
istamine was completely prevented by the highly selective histamine H-
3 receptor antagonist, clobenpropit but was resistant to antagonism by
triprolidine and cimetidine, antagonists at histamine H-1 and H-2 but
not H-3 receptors. 5 The H-3 receptor-induced inhibition of K+-evoked
release of acetylcholine was fully sensitive to tetrodotoxin (TTX). 6
The effects of intraperitoneal (i.p.) injection of imetit (5 mg kg(-1
)) and RAMH (5 mg kg(-1)) were tested on acetylcholine release and sho
rt term memory paradigms. Both drugs reduced 100 mM K+-evoked release
of cortical acetylcholine, and impaired object recognition and a passi
ve avoidance response. 7 These observations provide the first evidence
of a regulatory role of histamine H-3 receptors on cortical acetylcho
line release in vivo. Moreover, they suggest a role for histamine in l
earning and memory and may have implications for the treatment of dege
nerative disorders associated with impaired cholinergic function.